Grufity logo
Grufity logo
BPTH

BPTH - Bio-Path Holdings Inc Stock Price, Fair Value and News

$0.040.00 (0.00%)
Market Closed as of 30 Jul 2026, 04:00 pm ET

Price Targets

BPTH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BPTH Price Action

Last 90 days

-33.3%

Trailing 12 Months

-75%

BPTH RSI Chart

BPTH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BPTH Valuation

Market Cap

2.0M

Price/Earnings (Trailing)

-0.23

Price/Free Cashflow

-1.23

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

BPTH Fundamentals

BPTH Earnings

Earnings (TTM)

-8.7M

Earnings Growth (Yr)

90.53%

Earnings Growth (Qtr)

72.34%

BPTH Profitability

Return on Equity

102.46%

Return on Assets

-1.3K%

Free Cashflow Yield

-81.22%

BPTH Investor Care

Shares Dilution (1Y)

12.45%

Diluted EPS (TTM)

-1.09

Revenue & Growth

How Bio-Path Holdings Inc generates revenue and covers its expenses, based on the latest reported earnings.

About Bio-Path Holdings Inc

BPTH
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
 CEO
 WEBSITEbiopathholdings.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES10

Bio-Path Holdings Inc Frequently Asked Questions

BPTH is the stock ticker symbol of Bio-Path Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Jul 30 2026, market cap of Bio-Path Holdings Inc is 2.01 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

In the past 10 years, Bio-Path Holdings Inc has provided -0.7 (multiply by 100 for percentage) rate of return.